Publisert 23.07.2019

Canadian Patent - Notice of Allowance

Canadian Patent - Notice of Allowance

The Canadian Patent Office has issued a notice of allowance of additional US patent on Regenics technology. The patent is entitled: "USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION"

CA Patent Application No. 2,894,448

CA National Phase Entry of PCT/IB2013/003177

Int’l Filing Date: 06-Dec-2013 

Entitled: USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION

 For more info, please contact Henrik Lund at henrik.lund@regenics.no or mobile +47 90971219

 

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.